Below you'll find a list of all posts that have been tagged as “FDA”
As most of us know the battle for FDA to allow CBD containing dietary supplements continues to rage. Proponents of FDA action to allow CBD containing dietary supplements have been discouraged by FDA inaction in finding a path forward on that front. Despite such slow movement in that …
SafetyCall International’s Rick Kingston, PharmD, President of Regulatory & Scientific Affairs, will be speaking at the upcoming Dietary Supplements Regulatory Virtual Summit. This is the 5th joint regulatory summit sponsored by trade associations representing companies in this market space, including: AHPA, CHPA, CRN, NPA and UNPA, and in collaboration with the FDA. It is designed to update the industry …
SafetyCall recently attended the Canadian Health Food Association’s (CHFA) eastern regulatory conference on September 12-13th and exhibited at the trade show September 14-15th, 2019. This was the first conference and trade show SafetyCall has attended with CHFA. Plans are already in the works to attend the western show in February 2020.
Much of the talk at the conference mirrored the …
Recently, Harvard researchers conducted a study involving dietary supplements, later published in the Journal of Adolescent Health, to review adverse event reports from January 2004 to April 2015 using data from the FDA Adverse Event Reporting System (FAERS). The FAERS is a database that contains line listings of select fields of data from Adverse Event (AE) reports contained …
As Dan Fabricant, Director of the FDA’s Dietary Supplements Program, states in recent communications with Industry, he views the level of non-compliance of dietary supplement manufactures with cGMP’s (current good manufacturing practices) as astonishing. Based on audits that have been completed by the FDA’s compliance division they have estimated that nearly 70% of dietary supplement manufacturers are currently not up …
